c-MYC Antikörper (Thr358)
-
- Target Alle c-MYC (MYC) Antikörper anzeigen
- c-MYC (MYC) (Myc Proto-Oncogene protein (MYC))
-
Bindungsspezifität
- Thr358
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser c-MYC Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Immunogen
- cMyc antibody was raised in Rabbit using synthesized non-phosphopeptide derived from human cMyc around the phosphorylation site of Thr358 as the immunogen
- Isotyp
- IgG
- Top Product
- Discover our top product MYC Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:1000, IHC: 1:50-1:100, ELISA: 1:20000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- Lot specific
- Buffer
- PBS buffer (without Mg2+and Ca2+), pH 7.4, 150 mM NaCl with 0.02 % sodium azide and 50 % glycerol
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze/thaw cycles
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20 °C
-
- Target
- c-MYC (MYC) (Myc Proto-Oncogene protein (MYC))
- Andere Bezeichnung
- cMyc (MYC Produkte)
- Pathways
- p53 Signalweg, Zellzyklus, Sensory Perception of Sound, Transition Metal Ion Homeostasis, Mitotic G1-G1/S Phases, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus, Warburg Effekt
-